ALDX
Aldeyra Therapeutics, Inc.Recent alerts on ALDX
All signals →
Insider trade
Purchase by DOUGLAS RICHARD
74d ago
Insider trade
Purchase by Michael Alfieri (Principal Financial Officer)
74d ago
News
Aldeyra plunges as FDA rejects dry eye disease therapy
77d ago
SEC filing
ALDX Receives FDA Complete Response Letter for Reproxalap NDA, $70M Cash Supports 2028 Ops
77d ago
News
Catalyst Watch: Nvidia's GTC Conference, FOMC meeting, Okta event, and triple-witching day
81d ago
News
Mid to low cap healthcare stocks with the strongest earnings momentum
137d ago
News
Alveus Therapeutics Launches with $160 Million Series A Financing to Advance Next-Generation Therapies for Obesity and Metabolic Diseases
145d ago
News
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease – Company Announcement - FT.com
168d ago
Scanner
Unusual volume (z=2.6)
168d ago
News
Aldeyra Therapeutics Announces PDUFA Extension of the New Drug Application of Reproxalap for the Treatment of Dry Eye Disease – Company Announcement - FT.com
168d ago
Get push alerts for ALDX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS